Jiangsu Hualan New Pharmaceutical Material Co.,Ltd. (SZSE:301093) commences share repurchases on June 5, 2023, under the program mandated by the shareholders in the Extraordinary General Meeting held on May 26, 2023. As per the mandate, the company is authorized to repurchase its own shares for a total of CNY 200 million. The shares will be purchased at a price not exceeding CNY 49.5 per share. The repurchased shares will be cancelled thereby reducing the registered capital. The program will be funded from the excess funds raised by the company. The program will be valid for 12 months from the date of the shareholder's meeting.

On June 28, 2023, the company announced that it has adjusted its repurchase price from CNY 49.5 per share to CNY 49.20 per share.